.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
UBS
Citi
Cerilliant
Mallinckrodt
Federal Trade Commission
AstraZeneca
Boehringer Ingelheim
Cipla
Argus Health

Generated: July 22, 2017

DrugPatentWatch Database Preview

Vorinostat - Generic Drug Details

« Back to Dashboard

What are the generic sources for vorinostat and what is the scope of vorinostat freedom to operate?

Vorinostat
is the generic ingredient in one branded drug marketed by Merck and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vorinostat has one hundred and twenty-eight patent family members in thirty-five countries.

There are two drug master file entries for vorinostat. One supplier is listed for this compound.

Summary for Generic Name: vorinostat

Tradenames:1
Patents:9
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list76
Clinical Trials: see list245
Patent Applications: see list7,257
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:vorinostat at DailyMed

Pharmacology for Ingredient: vorinostat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
ZOLINZA
vorinostat
CAPSULE;ORAL021991-001Oct 6, 2006RXYesYes7,732,490► Subscribe ► Subscribe
Merck
ZOLINZA
vorinostat
CAPSULE;ORAL021991-001Oct 6, 2006RXYesYes7,456,219► SubscribeY ► Subscribe
Merck
ZOLINZA
vorinostat
CAPSULE;ORAL021991-001Oct 6, 2006RXYesYes8,093,295► SubscribeY ► Subscribe
Merck
ZOLINZA
vorinostat
CAPSULE;ORAL021991-001Oct 6, 2006RXYesYes8,450,372► Subscribe ► Subscribe
Merck
ZOLINZA
vorinostat
CAPSULE;ORAL021991-001Oct 6, 2006RXYesYes8,067,472► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: vorinostat

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
ZOLINZA
vorinostat
CAPSULE;ORAL021991-001Oct 6, 20066,087,367► Subscribe
Merck
ZOLINZA
vorinostat
CAPSULE;ORAL021991-001Oct 6, 2006RE38506► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: vorinostat

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,148,257Methods of treating mesothelioma with suberoylanilide hydroxamic acid► Subscribe
7,847,122Polymorphs of suberoylanilide hydroxamic acid► Subscribe
8,288,440Formulations of suberoylanilide hydroxamic acid and methods for producing same► Subscribe
7,375,137Methods of treating cancer with HDAC inhibitors► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: vorinostat

Country Document Number Estimated Expiration
Ukraine83065► Subscribe
Australia2010201359► Subscribe
MexicoPA04008577► Subscribe
European Patent Office1689379► Subscribe
Nicaragua200700031► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Chubb
Cantor Fitzgerald
Mallinckrodt
Argus Health
McKesson
Moodys
Federal Trade Commission
Deloitte
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot